These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8773745)

  • 1. Neuroendocrinology of the polycystic ovary syndrome.
    Soule SG
    Baillieres Clin Endocrinol Metab; 1996 Apr; 10(2):205-19. PubMed ID: 8773745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulsatile gonadotrophin secretion in women with polycystic ovary syndrome after gonadotrophin-releasing hormone agonist treatment.
    Cheung AP; Lu JK; Chang RJ
    Hum Reprod; 1997 Jun; 12(6):1156-64. PubMed ID: 9221993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty.
    Blank SK; McCartney CR; Helm KD; Marshall JC
    Semin Reprod Med; 2007 Sep; 25(5):352-9. PubMed ID: 17710731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroendocrine control in polycystic ovary-like syndrome.
    Schoemaker J
    Gynecol Endocrinol; 1991 Dec; 5(4):277-88. PubMed ID: 1796749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioidergic regulation of LH pulsatility in women with polycystic ovary syndrome.
    Berga SL; Yen SS
    Clin Endocrinol (Oxf); 1989 Feb; 30(2):177-84. PubMed ID: 2532984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of changing pulse frequency in the regulation of ovulation.
    Marshall JC; Griffin ML
    Hum Reprod; 1993 Nov; 8 Suppl 2():57-61. PubMed ID: 8276970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of gonadotropin secretion: implications for polycystic ovary syndrome.
    McCartney CR; Eagleson CA; Marshall JC
    Semin Reprod Med; 2002 Nov; 20(4):317-26. PubMed ID: 12536355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome.
    Blank SK; McCartney CR; Marshall JC
    Hum Reprod Update; 2006; 12(4):351-61. PubMed ID: 16670102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroendocrine aspects of polycystic ovary syndrome.
    Marshall JC; Eagleson CA
    Endocrinol Metab Clin North Am; 1999 Jun; 28(2):295-324. PubMed ID: 10352920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy: a possible mechanism regulating emergence of the dominant follicle.
    Lockwood GM; Muttukrishna S; Groome NP; Matthews DR; Ledger WL
    J Clin Endocrinol Metab; 1998 May; 83(5):1730-5. PubMed ID: 9589683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of GnRH-stimulated LH release to episodic LH secretion and baseline endocrine-metabolic measures in women with polycystic ovary syndrome.
    Patel K; Coffler MS; Dahan MH; Malcom PJ; Deutsch R; Chang RJ
    Clin Endocrinol (Oxf); 2004 Jan; 60(1):67-74. PubMed ID: 14678290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reproductive neuroendocrine dysfunction in polycystic ovary syndrome: insight from animal models.
    Roland AV; Moenter SM
    Front Neuroendocrinol; 2014 Oct; 35(4):494-511. PubMed ID: 24747343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome.
    Nugent D; Vandekerckhove P; Hughes E; Arnot M; Lilford R
    Cochrane Database Syst Rev; 2000; (4):CD000410. PubMed ID: 11034687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pituitary responsiveness to gonadotrophin-releasing hormone agonist stimulation: a dose-response comparison of luteinizing hormone/follicle-stimulating hormone secretion in women with polycystic ovary syndrome and normal women.
    Cheung AP; Chang RJ
    Hum Reprod; 1995 May; 10(5):1054-9. PubMed ID: 7657740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological pulses in PCOS.
    Coyle C; Campbell RE
    Mol Cell Endocrinol; 2019 Dec; 498():110561. PubMed ID: 31461666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothalamic-pituitary, ovarian and adrenal contributions to polycystic ovary syndrome.
    Baskind NE; Balen AH
    Best Pract Res Clin Obstet Gynaecol; 2016 Nov; 37():80-97. PubMed ID: 27137106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous administration of pulsatile gonadotropin-releasing hormone decreases serum follicle-stimulating hormone and luteinizing hormone levels in women with polycystic ovary syndrome: a preliminary study.
    Graña-Barcia M; Liz-Lestón J; Lado-Abeal J
    Fertil Steril; 2005 May; 83(5):1466-72. PubMed ID: 15866586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased luteinizing hormone secretion in women with polycystic ovary syndrome is unaltered by prolonged insulin infusion.
    Patel K; Coffler MS; Dahan MH; Yoo RY; Lawson MA; Malcom PJ; Chang RJ
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5456-61. PubMed ID: 14602789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gonadotrophin regulation and clinical applications of GnRH.
    Belchetz PE
    Clin Endocrinol Metab; 1983 Nov; 12(3):619-40. PubMed ID: 6323066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity.
    Arroyo A; Laughlin GA; Morales AJ; Yen SS
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3728-33. PubMed ID: 9360532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.